Quantcast

Latest Cancer Research Stories

2014-07-03 23:03:20

Pediatric patients, families, and physicians joined together to introduce revamped quarters for the Food for Life program. New York, NY (PRWEB) July 03, 2014 Pediatric patients and their families recently joined physicians from The Icahn School of Medicine at Mount Sinai and representatives from the Genetic Disease Foundation (GDF) to introduce revamped quarters for the Food for Life program, which serves patients in Mount Sinai’s Program for Inherited Metabolic Diseases – one of the...

2014-07-01 16:30:34

GRAND RAPIDS, Mich., July 1, 2014 /PRNewswire/ -- Van Andel Institute will host the fifth annual Origins of Cancer symposium, Friday, July 11, 2014. http://photos.prnewswire.com/prnvar/20140417/76339 The one-day symposium, held in partnership with the Foundation for Advanced Cancer Studies, Inc. (FACS), brings together medical and scientific experts from around the world to discuss the origins of cancer. This year's theme, Beyond the Tumor Cell, highlights inflammation and immune...

2014-07-01 11:10:06

American Association for Cancer Research A new approach demonstrated that the recognition of unique cancer mutations appeared to be responsible for complete cancer regressions in two metastatic melanoma patients treated with a type of immunotherapy called adoptive T-cell therapy. This new approach may help develop more effective cancer immunotherapies, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. "This study...

2014-06-30 12:32:22

NEW YORK, June 30, 2014 /PRNewswire/ -- FDNA(R) (http://www.fdna.com) - a pioneer in computer-aided dysmorphology analysis is proud to announce that four of Europe's leading thought leaders in genetics and human dysmorphology have been appointed to the steering committee of its Scientific Advisory Board (SAB). These appointments further strengthen the SABs strategic role in assisting FDNA on its mission to save lives and improve the quality of life of patients with rare or...

2014-06-30 08:30:41

SAN DIEGO and CHICAGO, June 30, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), the Robert H. Lurie Comprehensive Cancer Center of Northwestern University (Lurie Cancer Center) and the Northwestern Medicine Developmental Therapeutics Institute (NMDTI) have entered into a strategic partnership to conduct a translational research program designed to assess the utility of Trovagene's urine-based cell-free oncogene mutation monitoring technology in clinical practice....

2014-06-27 15:18:52

UT Southwestern Medical Center UT Southwestern cancer researchers have identified a promising molecule that blocks bone destruction and, therefore, could provide a potential therapeutic target for osteoporosis and bone metastases of cancer. The molecule, miR-34a, belongs to a family of small molecules called microRNAs (miRNAs) that serve as brakes to help regulate how much of a protein is made, which in turn, determines how cells respond. UT Southwestern researchers found that mice...

2014-06-24 14:07:18

Centro Nacional de Investigaciones Oncologicas (CNIO) New mutations in cohesin proteins, which are closely associated with cell division, are very common in various types of cancers such as bladder cancer and melanoma Massive sequencing of cancer genomes brings to light new genes every day that could be involved in the process of tumour formation. A good example of this is cohesin, a ring-shaped protein complex that embraces DNA to control cell division. Just a few months ago, and...

2014-06-24 14:03:33

Mayo Clinic A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting. Their study, published in Cancer Research, reveals that the gene NPTX2, plays an essential role in this cancer type, which is resistant to common chemotherapy and has a five-year overall survival rate of less than 10 percent in patients with metastatic disease....

2014-06-24 12:28:21

WILLIAMSBURG, Va., June 24, 2014 /PRNewswire/ -- The Snow Companies has been named a winner in the 35th Annual Telly Awards. The video entitled, "Multiple Myeloma in the African American Community" received a bronze award in the Non-Broadcast Health and Wellness category. Logo - http://photos.prnewswire.com/prnh/20140623/120706 "We are incredibly proud to be honored in this way," said Tyler James, Snow Companies' Vice President of Video Production. "At Snow, real patients share...

2014-06-24 12:27:39

PHILADELPHIA, June 24, 2014 /PRNewswire-USNewswire/ -- The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced the inaugural class of Pew-Stewart Scholars for Cancer Research. Five promising early-career scientists will receive funding for research aimed at finding cures for cancer using approaches that include genetics, pharmacology, and structural biology. "Cancer continues to take a terrible toll on human health worldwide, and creative approaches are vital...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related